Cargando…
Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients
BACKGROUND: Coronavirus disease (COVID-19) not only has a long-term effect on its survivors, it also affects their quality of life, including inducing depression as a possible manifestation of central nervous system disruption. Favipiravir shows promising efficacy as an antiviral drug for the treatm...
Autores principales: | Herman, Bumi, Bruni, Andrea, Zain, Ekachaeryanti, Dzulhadj, Azhar, Oo, Aye Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803217/ https://www.ncbi.nlm.nih.gov/pubmed/36584099 http://dx.doi.org/10.1371/journal.pone.0279184 |
Ejemplares similares
-
Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study
por: Herman, Bumi, et al.
Publicado: (2022) -
Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia
por: Herman, Bumi, et al.
Publicado: (2021) -
Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population
por: Herman, Bumi, et al.
Publicado: (2023) -
Role of favipiravir in the treatment of COVID-19
por: Joshi, Shashank, et al.
Publicado: (2021) -
Favipiravir for COVID-19 in a Patient on Hemodialysis
por: Hirai, Daisuke, et al.
Publicado: (2021)